Ernexa Therapeutics Inc. - 8-K Filing

Ernexa Therapeutics Inc. amends consulting agreement for CFO Mark J. Keeley to include monthly cash compensation. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $ERNA

Read the full article at SEC EDGAR

More Regulatory news